d-alpha tocopherol has been researched along with Glaucoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (19.05) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X; Huang, J; Li, Q; Li, X; Liu, H; Liu, X; Lu, Y; Luo, L; Shi, Y; Wang, S; You, J; Zhang, J; Zhou, H | 1 |
| Honrubia, FM; Larrosa, JM; Pinilla, I; Polo, V | 1 |
| Tanito, M | 1 |
| Bes-Rastrollo, M; Fernandez-Montero, A; Gándara, E; Hershey, MS; Kales, S; López-Gil, JF; Martínez-González, MÁ; Moreno-Galarraga, L; Moreno-Montañés, J | 1 |
| Huang, L; Jiang, C; Jin, Q; Jin, Z; Li, H; Liu, Y; Oswald, J; Song, X; Wang, F; Wu, J; Zhou, Y | 1 |
| Aktaş, Z; Çolak, A; Ekicier Acar, S; Sarıcaoğlu, MS; Sepici Dinçel, A | 1 |
| Lin, SC; Singh, K; Wang, SY | 1 |
| Moriniere, J; Welge-Lussen, U; Yu, AL | 1 |
| Ahmad, FJ; Anwar, M; Garg, V; Jain, GK; Khar, RK; Talegaonkar, S; Warsi, MH | 1 |
| Coffin, J; Pelletier, AL; Rojas-Roldan, L | 1 |
| Bravo-Osuna, I; Checa-Casalengua, P; García-Caballero, C; García-Feijoo, J; García-Martín, E; Herrero-Vanrell, R; Molina-Martínez, IT; Polo-Llorens, V; Prieto-Calvo, E | 1 |
| Chen, CF; Hsu, SY; Ko, ML; Peng, PH | 1 |
| Bravo-Osuna, I; Checa-Casalengua, P; Herrero-Vanrell, R; Jiang, C; Molina-Martínez, IT; Tucker, BA; Young, MJ | 1 |
| Ben-Shlomo, A; Chauhan, A; Mackay, EO; Peng, CC; Plummer, CE | 1 |
| Burke, MT; Carbia, BE; Chauhan, A; Peng, CC; Plummer, C | 1 |
| Desmettre, T; Rouland, JF | 1 |
| Bendala-Tufanisco, E; Grisolía, S | 1 |
| Dobritsa, TA; Kramorenko, IuS; Mustafina, ZhG; Ul'danov, GA | 1 |
| Stark, H | 1 |
| Weiss, H | 1 |
| Ernyei, S | 1 |
3 review(s) available for d-alpha tocopherol and Glaucoma
| Article | Year |
|---|---|
Reported evidence of vitamin E protection against cataract and glaucoma.
Topics: Aged; Cataract; Cross-Sectional Studies; Glaucoma; Humans; Prospective Studies; Vitamin E | 2021 |
Vision Loss in Older Adults.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antihypertensive Agents; Ascorbic Acid; Bevacizumab; Blindness; Cataract; Cataract Extraction; Diabetic Retinopathy; Fenofibrate; Glaucoma; Humans; Hypolipidemic Agents; Intravitreal Injections; Light Coagulation; Macular Degeneration; Mass Screening; Practice Guidelines as Topic; Ranibizumab; Vision Disorders; Vision, Low; Vitamin E; Vitamins | 2016 |
[Hypothesis on the role of nutritional factors in ocular hypertension and glaucoma].
Topics: Animals; Antioxidants; Apoptosis; Diet; Dietary Fats; Disease Models, Animal; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; Follow-Up Studies; Glaucoma; Glaucoma, Open-Angle; Glutathione; Heat-Shock Proteins; Humans; Intraocular Pressure; Male; Nutritional Physiological Phenomena; Ocular Hypertension; Optic Atrophy; Oxidative Stress; Primates; Prospective Studies; Rats; Risk Factors; Surveys and Questionnaires; Time Factors; Trabecular Meshwork; Vitamin E | 2005 |
18 other study(ies) available for d-alpha tocopherol and Glaucoma
| Article | Year |
|---|---|
Antioxidant nanoemulsion loaded with latanoprost enables highly effective glaucoma treatment.
Topics: alpha-Tocopherol; Antihypertensive Agents; Antioxidants; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Reactive Oxygen Species | 2023 |
Alpha-tocopherol derivatives in an experimental model of filtering surgery.
Topics: alpha-Tocopherol; Animals; Anterior Chamber; Filtering Surgery; Glaucoma; Inflammation; Intraocular Pressure; Rabbits; Time Factors; Tocopherols; Vitamin E | 1999 |
ACE-Vitamin Index and Risk of Glaucoma: The SUN Project.
Topics: Antioxidants; Ascorbic Acid; Dietary Supplements; Glaucoma; Humans; Male; Vitamin A; Vitamin E; Vitamins | 2022 |
TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma.
Topics: Animals; Carbonic Anhydrase Inhibitors; Cell Line; Chemistry, Pharmaceutical; Cornea; Delayed-Action Preparations; Drug Delivery Systems; Glaucoma; Intraocular Pressure; Liposomes; Male; Mice; Nanoparticles; Particle Size; Permeability; Rabbits; Sulfonamides; Thiazines; Vitamin E | 2018 |
Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model.
Topics: Administration, Ophthalmic; Animals; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Calcium-Binding Proteins; Disease Models, Animal; Drug Combinations; Glaucoma; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Microfilament Proteins; Neuroprotective Agents; Ophthalmic Solutions; Optic Nerve Injuries; Rats; Rats, Wistar; Retinal Ganglion Cells; Transcription Factor Brn-3A; Ubiquinone; Vitamin E | 2020 |
Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population-based sample of the United States.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Cross-Sectional Studies; Dietary Supplements; Female; Glaucoma; Humans; Male; Middle Aged; Odds Ratio; United States; Vitamin A; Vitamin E; Vitamins | 2013 |
Vitamin E reduces TGF-beta2-induced changes in human trabecular meshwork cells.
Topics: Adult; alpha-Crystallins; Antioxidants; beta-Crystallins; Drug Interactions; Extracellular Space; Female; Fibronectins; Gene Expression; Glaucoma; Humans; Male; Matrix Metalloproteinase 2; Middle Aged; Primary Cell Culture; Trabecular Meshwork; Transforming Growth Factor beta2; Vitamin E | 2013 |
Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits.
Topics: Animals; Carbonic Anhydrase Inhibitors; Glaucoma; Intraocular Pressure; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Ocular Hypertension; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Radionuclide Imaging; Sulfonamides; Thiophenes; Vitamin A; Vitamin E | 2014 |
Six month delivery of GDNF from PLGA/vitamin E biodegradable microspheres after intravitreal injection in rabbits.
Topics: Animals; Drug Carriers; Drug Liberation; Female; Glaucoma; Glial Cell Line-Derived Neurotrophic Factor; Humans; Intravitreal Injections; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Vitamin E | 2017 |
Dietary deficiency of vitamin E aggravates retinal ganglion cell death in experimental glaucoma of rats.
Topics: Animals; Apoptosis; Catalase; Cell Count; Diet; Disease Models, Animal; Female; Glaucoma; Glutathione; Intraocular Pressure; Lipid Peroxidation; Lipid Peroxides; Oxidative Stress; Rats; Rats, Wistar; Retinal Degeneration; Retinal Ganglion Cells; Superoxide Dismutase; Vitamin E; Vitamin E Deficiency | 2010 |
Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure.
Topics: Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Drug Carriers; Drug Combinations; Drug Compounding; Glaucoma; Glial Cell Line-Derived Neurotrophic Factor; Intraocular Pressure; Intravitreal Injections; Lactic Acid; Male; Mice; Mice, Inbred Strains; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Inbred BN; Retinal Ganglion Cells; Surface Properties; Vitamin E | 2011 |
Drug delivery by contact lens in spontaneously glaucomatous dogs.
Topics: Animals; Antihypertensive Agents; Biological Availability; Contact Lenses, Hydrophilic; Disease Models, Animal; Dogs; Drug Delivery Systems; Glaucoma; Intraocular Pressure; Ophthalmic Solutions; Timolol; Vitamin E | 2012 |
Extended drug delivery by contact lenses for glaucoma therapy.
Topics: Animals; Antihypertensive Agents; Contact Lenses, Extended-Wear; Dogs; Drug Delivery Systems; Eye; Glaucoma; Intraocular Pressure; Ophthalmic Solutions; Timolol; Vitamin E | 2012 |
[Antioxidants treatment of ocular diseases].
Topics: Antioxidants; Ascorbic Acid; Cataract; Clinical Trials as Topic; Dietary Supplements; Eye Diseases; Glaucoma; Humans; Macular Degeneration; Risk Factors; Smoking; Vitamin E; Vitamins | 2007 |
[Correction of cellular immunity in primary glaucoma patients].
Topics: Adult; Aged; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Glaucoma; Humans; Immunity, Cellular; Leukocyte Count; Middle Aged; Vasodilator Agents; Vitamin A; Vitamin E | 1987 |
[Studies with the computer-guided perimeter "Peritest" on the effect of Cosaldon A+E on glaucomatous visual field defects].
Topics: Adult; Aged; Computers; Drug Combinations; Female; Glaucoma; Humans; Male; Middle Aged; Nicotinic Acids; Theobromine; Visual Field Tests; Visual Fields; Vitamin A; Vitamin E | 1985 |
[A clinical experimental study on the therapeutically effective component of retinal phosphatides (author's transl)].
Topics: Amino Acids; Animals; Cattle; Dose-Response Relationship, Drug; Glaucoma; Humans; Injections; Myocardium; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Retina; Retinal Diseases; Tissue Extracts; Visual Fields; Vitamin E | 1974 |
[General treatment of primary glaucoma with vitamin E. (A therapeutic suggestion)].
Topics: Adult; Aged; Female; Glaucoma; Humans; Male; Middle Aged; Tonometry, Ocular; Vision Disorders; Vitamin E | 1966 |